X-linked adrenoleukodystrophy: The Australasian experience

American Journal of Medical Genetics

Volumn 76, Issue 5, 1998, Pages 420-423

  Kirk, Edwin P E ^a   Fletcher, Janice M ^a   Sharp, Peter ^a   Carey, Bill ^a   Poulos, Alfred ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Carrier testing; Incidence; Phenotype; X linked adrenoleukodystrophy

Indexed keywords

ADDISON DISEASE; ADRENOLEUKODYSTROPHY; ARTICLE; ASIAN; AUSTRALIA; GENETIC LINKAGE; HETEROZYGOTE DETECTION; HUMAN; INCIDENCE; NEW ZEALAND; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; X CHROMOSOME LINKED DISORDER;

ADRENOLEUKODYSTROPHY; AUSTRALIA; FATTY ACIDS; FEMALE; HETEROZYGOTE; HUMANS; LINKAGE (GENETICS); MALE; NEW ZEALAND; PACIFIC ISLANDS; PHENOTYPE; RETROSPECTIVE STUDIES; X CHROMOSOME;

EID: 0032513570     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980413)76:5<420::AID-AJMG10>3.0.CO;2-O     Document Type: Article

References (22)

1. Aubourg P, Chaussain J-L (1991): Adrenoleukodystrophy presenting as Addison's disease in children and adults. Trends Endocrinol Metab 2:49-52.
2. Aubourg P, Blanche S, Jambaqué I, Rocchiccioli F, Kalifa G, Naud-Saudreau C (1990): Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860-1866.
3. Aubourg P, Adamsbaum C, Lavallard-Rousseau M-C, Rocchiccioli F, Cartier N, Jambaqué I (1993): A two-year trial of oleic and erucic acids ("Lorenzo's Oil") as treatment for adrenomyeloneuropathy. N Engl J Med 329:745-752.
4. Berkovic SF, Zajac JD, Warbuton DJ, Merory JR, Fellenberg AJ, Poulos A, Pollard AC (1983): Adrenomyeloneuropathy: Clinical and biochemical diagnosis. Aust NZ J Med 13:594-600.
5. Braun A, Ambach H, Kammerer S, Rolinski B, Stöckler S, Rabl W, Gartner J, Zierz S, Roscher AA (1995): Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes. Am J Hum Genet 56:854-861.
6. Chan V, Chan TK, Liu VWS, Wong ACK (1988): Restriction fragment length polymorphisms associated with factor VIII:C gene in Chinese. Hum Genet 79:128-131
7. Feigenbaum V, Lombard-Platet G, Guidoux S, Sarde C-O, Mandel J-L, Auborg P (1996): Mutational and protein analysis of patients and heterozygous women with X-Linked adrenoleukodystrophy. Am J Hum Genet 58:1135-1144.
8. Graham GE, MacLeod PM, Lillicrap DP, Bridge PJ (1992): Gonadal mosaicism in a family with adrenoleukodystrophy: Molecular diagnosis of carrier status among daughters of a gonadal mosaic when direct detection of the mutation is not possible. J Inherited Metab Dis 15:68-74.
9. Jorge P, Quelhas D, Oliviera P, Pinto R, Nogueira A (1994): X-linked adrenoleukodystrophy in patients with idiopathic Addison disease. Eur J Pediatr 153:594-597.
10. Korenke GC, Hunneman DH, Kohler J, Stöckler S, Landmark K, Hanefeld F (1995): Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: Effect on clinical, biochemical and neurophysiological parameters. Eur J Pediatr 154:64-70.
11. Korenke GC, Fuchs S, Krasemann E, Doerr HG, Wilichowski E, Hunnerman DH, Hanefeld F (1996): Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann Neurol 40:254-257.
12. Krasemann EW, Meier V, Korenke GC, Hunneman DH, Hanefeld F (1996): Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy. Hum Genet 97:194-197.
13. Ligtenberg MJL, Kemp S, Sarde C-O, Mandel JL, Chimini G (1995): Spectrum of mutations in the gene encoding the adrenoleukodystrophy protein. Am J Hum Genet 56:44-50.
14. Moser HW (1993): (Film review). Lorenzo's Oil. Lancet 341:544.
15. Moser HW, Moser AE, Singh I, O'Neill BP (1984): Adrenoleukodystrophy. Survey of 303 cases: Biochemistry, diagnosis, and therapy. Ann Neurol 16:628-641.
16. Moser HW, Smith KD, Moser AB (1995): X-Linked Adrenoleukodystrophy. In Scriver CR, Beaudet AL, Sly WS, Valle D (eds): "The Metabolic and Molecular Bases of Inherited Disease." New York: McGraw-Hill, pp 2325-2349.
17. Mosser J, Douar A-M, Sarde C-O, Kioschis P, Feil R, Moser HW, Poustka A-M, Mandel J-L, Aubourg P (1993): Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726-730.
18. Poulos A, Gibson R, Sharp P, Beckman K, Grattan-Smith P (1994): Very long chain fats in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Ann Neurol 36:741-746.
19. Rasmussen M, Moser AB, Borel J, Khangoora S , Moser HW (1994): Brain, liver and adipose tissue erucic and very long chain fatty acid levels in adrenoelukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's Oil). Neuromed Res 19:1073-1082.
20. Richards B, Heilig R, Oberlé I, Storjohann L, Horn GT (1991): Rapid PCR analysis of the St14 (DXS52) VNTR. Nucl Acids Res 19:1944.
21. Sarde C-O, Mosser J, Kioschis P, Kretz C, Vicaire S, Auborg P, Poustka A, Mandel J-L (1994): Genomic organization of the adrenoleukodystrophy gene. Genomics 22:13-20.
22. van Geel BM, Assies JA, Weverling GJ, Earth PG (1994): Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in the Netherlands: A survey of 30 kindreds. Neurology 44:2343-2346.